BioArctic AB (LTS:0RV2) Cyclically Adjusted FCF per Share: kr2.16 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RV2 BioArctic AB LTS:0RV2
75 GF Score
Price kr299.30
GF Value kr484.54
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is BioArctic AB Cyclically Adjusted FCF per Share?

BioArctic AB LTS:0RV2 +0.71% 75 Cyclically Adjusted FCF per Share is kr2.16 as of Mar. 2026. GuruFocus rates LTS:0RV2 with a GF Score™ of 75/100 and a GF Value™ of kr484.54 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

BioArctic AB's adjusted free cash flow per share for the three months ended in Mar. 2026 was kr-1.868. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr2.16 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-21), BioArctic AB's current stock price is kr299.30. BioArctic AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was kr2.16. BioArctic AB's Cyclically Adjusted Price-to-FCF of today is 138.56.

During the past 11 years, the highest Cyclically Adjusted Price-to-FCF of BioArctic AB was 164.67. The lowest was 139.91. And the median was 149.54.


BioArctic AB  (LTS:0RV2) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

BioArctic AB's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=299.30/2.16
=138.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted Price-to-FCF of BioArctic AB was 164.67. The lowest was 139.91. And the median was 149.54.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


BioArctic AB Cyclically Adjusted FCF per Share Related Terms


BioArctic AB Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for BioArctic AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioArctic AB Cyclically Adjusted FCF per Share Chart

BioArctic AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BioArctic AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 2.16

LTS:0RV2 vs VRTX, REGN, ALNY: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, BioArctic AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioArctic AB Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioArctic AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where BioArctic AB's Cyclically Adjusted Price-to-FCF falls into.


LTS:0RV2
75GF Score
BioArctic AB LTS:0RV2
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioArctic AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioArctic AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-1.868/133.5600*133.5600
=-1.868

Current CPI (Mar. 2026) = 133.5600.

BioArctic AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201512 0.000 100.276 0.000
201609 -0.111 101.138 -0.147
201612 8.013 102.022 10.490
201703 -0.436 102.022 -0.571
201706 -0.314 102.752 -0.408
201709 -0.268 103.279 -0.347
201712 -0.519 103.793 -0.668
201803 -0.490 103.962 -0.630
201806 -0.438 104.875 -0.558
201809 -0.357 105.679 -0.451
201812 -0.996 105.912 -1.256
201903 3.789 105.886 4.779
201906 1.104 106.742 1.381
201909 -0.561 107.214 -0.699
201912 -0.616 107.766 -0.763
202003 -0.411 106.563 -0.515
202006 -0.225 107.498 -0.280
202009 -0.107 107.635 -0.133
202012 -0.300 108.296 -0.370
202103 -0.423 108.360 -0.521
202106 -0.325 108.928 -0.398
202109 -0.393 110.338 -0.476
202112 -0.430 112.486 -0.511
202203 -0.448 114.825 -0.521
202206 -0.518 118.384 -0.584
202209 1.259 122.296 1.375
202212 -0.644 126.365 -0.681
202303 3.368 127.042 3.541
202306 -0.724 129.407 -0.747
202309 -0.594 130.224 -0.609
202312 1.425 131.912 1.443
202403 -1.295 132.205 -1.308
202406 -1.068 132.716 -1.075
202409 -0.908 132.304 -0.917
202412 -0.310 132.987 -0.311
202503 0.133 132.825 0.134
202506 12.958 133.699 12.945
202509 -0.465 133.480 -0.465
202512 3.535 133.390 3.540
202603 -1.868 133.560 -1.868

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of kr2.16 mean?
BioArctic AB (LTS:0RV2) has a Cyclically Adjusted FCF per Share of kr2.16 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on BioArctic AB and its competitors.
Is BioArctic AB's Cyclically Adjusted FCF per Share too high?
BioArctic AB's current Cyclically Adjusted FCF per Share is kr2.16. Overall, BioArctic AB has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BioArctic AB's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
BioArctic AB's Cyclically Adjusted FCF per Share of kr2.16 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on BioArctic AB and its competitors. BioArctic AB's current Cyclically Adjusted FCF per Share is kr2.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioArctic AB stock overvalued right now?
Based on GuruFocus' analysis, BioArctic AB (LTS:0RV2) is currently considered Significantly Undervalued. The stock's GF Value™ is kr484.54, compared to a current price of kr299.30 — trading 38.2% below its estimated fair value. The current Cyclically Adjusted FCF per Share is kr2.16. BioArctic AB's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For BioArctic AB (LTS:0RV2), the current Cyclically Adjusted FCF per Share is kr2.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioArctic AB (LTS:0RV2) Overvalued in 2026?

Based on GuruFocus' analysis, BioArctic AB stock appears to be undervalued. The current stock price of kr299.30 is trading 38.2% below its estimated GF Value™ of kr484.54. GuruFocus considers BioArctic AB to be Significantly Undervalued.

Key valuation signals for LTS:0RV2:

  • Cyclically Adjusted FCF per Share: kr2.16
  • GF Value™: kr484.54 vs. price of kr299.30 (38.2% below fair value)
  • GF Score™: 75/100 with 2 warning signs

No single metric tells the full story. See the LTS:0RV2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioArctic AB Business Description

Address Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.
75GF Score

Get the complete analysis for LTS:0RV2

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr299.30
Price
kr484.54
GF Value